Display options
Cite
Roberts RM, Albert AP, Johnson DD, et al. Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?. Health Serv Res Manag Epidemiol. 2015;2:2333392814568345doi: 10.1177/2333392814568345.
Roberts, R. M., Albert, A. P., Johnson, D. D., & Hicks, L. A. (2015). Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?. Health services research and managerial epidemiology, 22333392814568345. https://doi.org/10.1177/2333392814568345
Roberts, Rebecca M, et al. "Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?." Health services research and managerial epidemiology vol. 2 (2015): 2333392814568345. doi: https://doi.org/10.1177/2333392814568345
Roberts RM, Albert AP, Johnson DD, Hicks LA. Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?. Health Serv Res Manag Epidemiol. 2015 Jan 26;2:2333392814568345. doi: 10.1177/2333392814568345. eCollection 2015. PMID: 28462251; PMCID: PMC5266459.
Copy Download .nbib Format: NLM
Share it on

Health Serv Res Manag Epidemiol. 2015 Jan 26;2:2333392814568345. doi: 10.1177/2333392814568345. eCollection 2015.

Can Improving Knowledge of Antibiotic-Associated Adverse Drug Events Reduce Parent and Patient Demand for Antibiotics?.

Health services research and managerial epidemiology

Rebecca M Roberts, Alison P Albert, Darcia D Johnson, Lauri A Hicks

Affiliations

  1. Get Smart: Know When Antibiotics Work program, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  2. Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

PMID: 28462251 PMCID: PMC5266459 DOI: 10.1177/2333392814568345

Abstract

BACKGROUND: According to the Centers for Disease Control and Prevention, at least 2 million people are infected and 23,000 die each year in the United States as a result of antibiotic-resistant bacterial infections. Antibiotic use is the most important factor contributing to antibiotic resistance and overuse is common, especially for upper respiratory tract infections. There is a perception among the public, as well as some health care providers, that antibiotics are harmless. We conducted formative research to explore patient and parent knowledge and attitudes relating to antibiotic use and adverse drug events (ADEs).

METHODS: Six computer-assisted telephone focus groups were conducted in October and November 2010 with adult patients and mothers of young children. The focus groups were developed to engage participants in discussion about their knowledge and attitudes regarding antibiotic resistance and ADEs associated with antibiotic use.

RESULTS: Nearly all mothers were familiar with the possibility of "side effects" with prescription medications, including antibiotics. However, very few mothers were familiar with severe antibiotic-associated ADEs and nearly all felt strongly that this information should be shared with parents at the time a prescription is recommended or written for their child. Adult participants did not believe that the potential for ADEs was a significant issue for adults and most reported never discussing the potential for adverse events with their provider.

CONCLUSIONS: Parents were receptive to appropriate antibiotic use messaging around ADEs. We learned that ADE messages did not resonate with adults in the same way they did with mothers of young children.

Keywords: adverse drug events; antibiotics; focus groups; upper respiratory infections

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

  1. Emerg Infect Dis. 2014 Dec;20(12):2041-7 - PubMed
  2. JAMA. 2006 Oct 18;296(15):1858-66 - PubMed
  3. Clin Pediatr (Phila). 1998 Nov;37(11):665-71 - PubMed
  4. J Urol. 2013 Jul;190(1):222-7 - PubMed
  5. MMWR Morb Mortal Wkly Rep. 2011 Sep 2;60(34):1153-6 - PubMed
  6. Emerg Infect Dis. 2003 Sep;9(9):1128-35 - PubMed
  7. BMJ. 2010 May 18;340:c2096 - PubMed
  8. Semin Pediatr Infect Dis. 2004 Jan;15(1):41-51 - PubMed
  9. Pediatrics. 2001 Jan;107(1):E6 - PubMed
  10. BMJ. 2008 Oct 23;337:a1938 - PubMed
  11. Open Forum Infect Dis. 2015 Aug 11;2(3):ofv113 - PubMed
  12. Clin Infect Dis. 2001 Sep 15;33(6):757-62 - PubMed
  13. J Antimicrob Chemother. 2014 Jan;69(1):234-40 - PubMed
  14. Acad Emerg Med. 2006 Mar;13(3):288-94 - PubMed
  15. Pediatrics. 2011 Dec;128(6):1053-61 - PubMed
  16. BMJ. 1998 Sep 5;317(7159):637-42 - PubMed
  17. Arch Intern Med. 2012 Oct 22;172(19):1513-4 - PubMed
  18. Clin Infect Dis. 2011 Oct;53(7):631-9 - PubMed

Publication Types